Artificial Intelligence and Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
In this paper, we analyse the different advances in artificial intelligence (AI) approaches in multiple sclerosis (MS). AI applications in MS range across investigation of disease pathogenesis, diagnosis, treatment, and prognosis. A subset of AI, Machine learning (ML) models analyse various data sources, including magnetic resonance imaging (MRI), genetic, and clinical data, to distinguish MS from other conditions, predict disease progression, and personalize treatment strategies. Additionally, AI models have been extensively applied to lesion segmentation, identification of biomarkers, and prediction of outcomes, disease monitoring, and management. Despite the big promises of AI solutions, model interpretability and transparency remain critical for gaining clinician and patient trust in these methods. The future of AI in MS holds potential for open data initiatives that could feed ML models and increasing generalizability, the implementation of federated learning solutions for training the models addressing data sharing issues, and generative AI approaches to address challenges in model interpretability, and transparency. In conclusion, AI presents an opportunity to advance our understanding and management of MS. AI promises to aid clinicians in MS diagnosis and prognosis improving patient outcomes and quality of life, however ensuring the interpretability and transparency of AI-generated results is going to be key for facilitating the integration of AI into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation
Isensee, F., Jaeger, P. F., Kohl, S. A. A., Petersen, J., & Maier-Hein, K. H. (2021) · Nature Methods · doi:10.1038/s41592-020-01008-z · Cited by 10,477
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167 · cited 1×
“[ 6] The most recent revisions of the diagnostic criteria have placed an emphasis on increasing the sensitivity to allow an earlier diagnosis.”
BackgroundGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049 · cited 1×
“[4 , 5] The current diagnostic criteria for MS are codified in the 2017 McDonald criteria.”
BackgroundA review of applications in federated learning
Li, L., Fan, Y., Tse, M., & Lin, K.-Y. (2020) · Computers & Industrial Engineering · doi:10.1016/j.cie.2020.106854 · Cited by 1,559
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023
Haug, C. J., & Drazen, J. M. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2302038 · Cited by 1,215
Artificial Intelligence in Medicine: Today and Tomorrow
Briganti, G., & Le Moine, O. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00027 · Cited by 743
Wattjes, M. P., Ciccarelli, O., Reich, D. S., Banwell, B., de Stefano, N., Enzinger, C., Fazekas, F., Filippi, M., Frederiksen, J., Gasperini, C., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00095-8 · Cited by 674 · cited 1×
“[8] Although historically the diagnosis of MS relied on clin - ical features supported by MRI, blood tests, and cerebral spinal fluid (CSF) tests, the reliance on MRI has grown, so that now making a diagnosis without MRI features suggest - ing MS is the exception.”
The immunology of multiple sclerosis
Attfield, K. E., Jensen, L. T., Kaufmann, M., Friese, M. A., & Fugger, L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00718-z · Cited by 380 · cited 1×
“[4 , 5] The current diagnostic criteria for MS are codified in the 2017 McDonald criteria.”
BackgroundLocus for severity implicates CNS resilience in progression of multiple sclerosis
International Multiple Sclerosis Genetics Consortium, Harroud, A., Stridh, P., McCauley, J. L., Saarela, J., van den Bosch, A. M. R., Engelenburg, H. J., Beecham, A. H., Alfredsson, L., Alikhani, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06250-x · Cited by 285
Cited by
Onciul, R., Tataru, C.-I., Dumitru, A. V., Crivoi, C., Serban, M., Covache-Busuioc, R.-A., Radoi, M. P., & Toader, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020550 · Cited by 113
“These models are transforming the speed and efficiency of drug pipelines, particularly in conditions with complex pathophysiologies like epilepsy and multiple sclerosis [223].”
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61
Palantzas, A., & Anagnostouli, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178217 · Cited by 11
Metadata
- Authors
- Amin, M., Martínez-Heras, E., Ontaneda, D., & Prados Carrasco, F.
- Venue
- Current Neurology and Neuroscience Reports
- Published
- 2024-06-28
- Volume
- 24
- Issue
- 8
- Pages
- 233-243
- ISSN
- 1528-4042 (ISSN-L)
- 1534-6293
- OpenAlex
- W4400132091
- Cited by
- 57
- References
- 12
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Artificial Intelligence and Multiple Sclerosis. https://app.cochat.ai/papers/10.1007/s11910-024-01354-x
- The paper
- Amin, M., Martínez-Heras, E., Ontaneda, D., & Prados Carrasco, F. (2024). Artificial Intelligence and Multiple Sclerosis. Current Neurology and Neuroscience Reports. https://doi.org/10.1007/s11910-024-01354-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.